CN107073035B - 治疗铁缺乏的方法 - Google Patents

治疗铁缺乏的方法 Download PDF

Info

Publication number
CN107073035B
CN107073035B CN201580035310.XA CN201580035310A CN107073035B CN 107073035 B CN107073035 B CN 107073035B CN 201580035310 A CN201580035310 A CN 201580035310A CN 107073035 B CN107073035 B CN 107073035B
Authority
CN
China
Prior art keywords
iron
iron oxide
biocompatible
oxide nanoparticles
itrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580035310.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN107073035A (zh
Inventor
陈志隆
谢文元
林宸萱
林思佑
黄馨怡
许源宏
王先知
黄信荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jusheng Biomedical Co ltd
Original Assignee
Jusheng Biomedical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jusheng Biomedical Co ltd filed Critical Jusheng Biomedical Co ltd
Publication of CN107073035A publication Critical patent/CN107073035A/zh
Application granted granted Critical
Publication of CN107073035B publication Critical patent/CN107073035B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201580035310.XA 2014-07-11 2015-07-10 治疗铁缺乏的方法 Active CN107073035B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462023533P 2014-07-11 2014-07-11
US62/023,533 2014-07-11
PCT/CN2015/083765 WO2016004894A1 (en) 2014-07-11 2015-07-10 Method of treating iron deficiency

Publications (2)

Publication Number Publication Date
CN107073035A CN107073035A (zh) 2017-08-18
CN107073035B true CN107073035B (zh) 2020-08-28

Family

ID=53773226

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580035310.XA Active CN107073035B (zh) 2014-07-11 2015-07-10 治疗铁缺乏的方法

Country Status (10)

Country Link
US (1) US9492399B2 (enExample)
EP (1) EP2965754B1 (enExample)
JP (1) JP6630293B2 (enExample)
CN (1) CN107073035B (enExample)
ES (1) ES2654429T3 (enExample)
HU (1) HUE035242T2 (enExample)
PL (1) PL2965754T3 (enExample)
PT (1) PT2965754T (enExample)
TW (1) TWI689310B (enExample)
WO (1) WO2016004894A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157000B (zh) 2018-02-12 2022-05-31 巨生生医股份有限公司 生物相容性磁性材料
WO2024100213A1 (fr) 2022-11-10 2024-05-16 Université De Lorraine Nanoclusters de fer, leurs procédés d'obtention et leurs utilisations pour lutter contre les carences en fer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010034319A1 (en) * 2008-09-29 2010-04-01 Innovative Research And Development Co. (Inrad) Magnetite nanoparticles as a single dose treatment for iron deficiency anemia
CN102112158A (zh) * 2008-04-22 2011-06-29 财团法人工业技术研究院 生物相容性高分子与具有生物相容性的磁性纳米微粒

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US5554386A (en) 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US6099852A (en) * 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DE60043188D1 (de) 1999-04-09 2009-12-03 Amag Pharmaceuticals Inc Hitzebeständige umhüllte kolloidale eisenoxide
US6997863B2 (en) * 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
US20030190355A1 (en) 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
AU2003250971B2 (en) * 2002-07-24 2008-04-03 F. Hoffmann - La Roche Ag Polyethylene glycol aldehyde derivatives
US7462446B2 (en) 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods
US20110182805A1 (en) 2005-06-17 2011-07-28 Desimone Joseph M Nanoparticle fabrication methods, systems, and materials
DE102005059751A1 (de) 2005-12-09 2007-06-14 Ferropharm Gmbh Forschungslabor Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie
TWI293113B (en) 2005-12-23 2008-02-01 Ind Tech Res Inst Magnetic nanoparticles with fluorescent and specific targeting functions
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
TWI321133B (en) 2006-08-01 2010-03-01 Univ Kaohsiung Medical Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
ES2308901B1 (es) 2006-09-22 2009-10-30 Consejo Superior De Investigaciones Cientificas Sistemas que contienen nanoparticulas magneticas y polimeros, como nanocomposites y ferrofluidos, y sus aplicaciones.
US20110104073A1 (en) 2007-01-18 2011-05-05 Qi Zeng Iron/Iron Oxide Nanoparticle and Use Thereof
US20120003160A1 (en) 2007-06-29 2012-01-05 Amag Pharmaceuticals, Inc. Macrophage-Enhanced MRI (MEMRI) in a Single Imaging Session
TWI361082B (en) 2008-01-15 2012-04-01 Ind Tech Res Inst Biocompatible polymer and magnetic nanoparticle with biocompatibilities
WO2009120702A2 (en) 2008-03-25 2009-10-01 Emory University Elemental iron nanoparticles
US20090280063A1 (en) 2008-05-09 2009-11-12 General Electric Company Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
US8179999B2 (en) * 2008-08-08 2012-05-15 Nokia Corporation Decoding of blocks in radio communications
AU2009334868B2 (en) 2008-12-29 2015-11-05 Ge Healthcare Limited Nanoparticle contrast agents for diagnostic imaging
WO2010091183A2 (en) 2009-02-04 2010-08-12 The Regents Of The University Of Colorado, A Body Corporate Non-invasive detection of complement-mediated inflammation using cr2-targeted nanoparticles
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
GB2472446A (en) 2009-08-07 2011-02-09 Ct Fuer Angewandte Nanotechnologie Metal oxide particles coated with polyethylene glycol and their synthesis
WO2011052205A1 (ja) * 2009-10-30 2011-05-05 国立大学法人東京工業大学 ポリマー被覆フェライト微粒子および製造方法
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
WO2012092305A2 (en) * 2010-12-27 2012-07-05 Incube Labs, Llc Nanonized iron compositions and methods of use thereof
EP2526927A1 (de) * 2011-05-25 2012-11-28 Justus-Liebig-Universität Gießen Biokompatible Nano- und Mikropartikel beschichtet mit Stabilisatoren für die pulmonale Applikation
CN102349930B (zh) 2011-11-01 2013-07-10 东南大学 具有抗氧化活性的氧化铁纳米粒水凝胶剂
US9474810B2 (en) * 2012-03-02 2016-10-25 General Electric Company Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells
US9196405B2 (en) 2012-04-03 2015-11-24 Florida State University Research Foundation, Inc. Stable iron oxide nanoparticles and method of production
EP2647389A1 (en) * 2012-04-04 2013-10-09 Charité - Universitätsmedizin Berlin Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
US20150147276A1 (en) 2012-06-07 2015-05-28 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
US20130336897A1 (en) 2012-06-18 2013-12-19 Gerald L. Wolf Theranosis of macrophage-associated diseases with ultrasmall superparamagnetic iron oxide nanoparticles (uspio)
CN103251648B (zh) 2013-05-15 2015-08-05 乔敏 治疗血磷酸盐过多症及缺铁性贫血症的铁基蒙脱石药物及其制备方法
CN103341165B (zh) 2013-05-31 2015-04-01 上海师范大学 一种具有光热功能的Fe@Fe3O4纳米粒子及其制备方法和应用
CN103303981B (zh) 2013-07-04 2015-04-01 厦门大学 一种四氧化三铁纳米粒子及其制备方法和用途
CN103405790B (zh) 2013-07-15 2015-05-20 中国科学院过程工程研究所 一种高分子原位修饰的超顺磁性颗粒、制备方法及其用途
CN103469290B (zh) 2013-09-02 2016-01-13 南阳师范学院 一种合成超顺磁性Fe3O4纳米晶的方法
CN103601900A (zh) 2013-11-15 2014-02-26 无锡中科光远生物材料有限公司 一种具有靶向效应的纳米颗粒的制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102112158A (zh) * 2008-04-22 2011-06-29 财团法人工业技术研究院 生物相容性高分子与具有生物相容性的磁性纳米微粒
WO2010034319A1 (en) * 2008-09-29 2010-04-01 Innovative Research And Development Co. (Inrad) Magnetite nanoparticles as a single dose treatment for iron deficiency anemia

Also Published As

Publication number Publication date
CN107073035A (zh) 2017-08-18
WO2016004894A1 (en) 2016-01-14
TWI689310B (zh) 2020-04-01
US9492399B2 (en) 2016-11-15
PL2965754T3 (pl) 2018-04-30
US20160008292A1 (en) 2016-01-14
JP6630293B2 (ja) 2020-01-15
PT2965754T (pt) 2018-01-08
EP2965754A1 (en) 2016-01-13
ES2654429T3 (es) 2018-02-13
TW201625278A (zh) 2016-07-16
HUE035242T2 (en) 2018-05-02
JP2017524670A (ja) 2017-08-31
EP2965754B1 (en) 2017-10-04

Similar Documents

Publication Publication Date Title
US10369113B2 (en) Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
ES2885055T3 (es) Nanoparticulas de dioxido de silicio y el uso de las mismas para la vacunacion
Chang et al. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery
TWI394773B (zh) Novel block copolymers, microcell modifiers, and anticancer agents that are useful as an active ingredient
US20060216239A1 (en) Magnetic nanoparticle compositions and methods
US10730898B2 (en) Compound and use thereof and platinum complex and lipidosome thereof
US12268756B2 (en) Biocompatible magnetic materials
CN107073035B (zh) 治疗铁缺乏的方法
US20240000978A1 (en) Method for immune cell tracking
CN107951839B (zh) 一种具有电荷可翻转的聚离子型胶束遮蔽体系及其制备方法
CN104208709A (zh) 一种脑靶向水溶性药物负载及其制备方法与应用
CN117396227A (zh) siRNA递送载体
CN102614110A (zh) 稳定的聚乙二醇化药物型胶束组合物及其制备方法
US20250269044A1 (en) Psma-targeted dendrimer nanoplatform for cancer detection and therapy
CN120661510A (zh) 非甾体抗炎药与伊立替康的自组装偶联物制备方法和应用
KR20150001693A (ko) 헤파린-도세탁셀-토로콜산 접합체로 이루어진 표적성이 향상된 수용성 항암제 및 그의 제조방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant